Top news of the week: 17.08.2021.
Biotechnology
Vaccination
Vaccine
Health care
Royalties
Immunology
Healthcare
Meet Insider's 30 leaders under 40 transforming #healthcare 🏥
https://t.co/B0mlx36e5z https://t.co/LzJ5dnplNh
OpenMeet Insider's 30 leaders under 40 transforming healthcare
These are Insider's biggest healthcare stories for August 16.
RT @Reuters_Health: GlaxoSmithKline (GSK.L) and CureVac (https://t.co/LIkrvtMBzY) said a study on macaque monkeys showed their jointly-developed mRNA COVID-19 vaccine candidate to be "strongly improved" in protecting against the virus compared with CureVac's first attempt. https://t.co/sSSc5WMNGq
Open
GSK, CureVac's next-gen COVID-19 vaccine shows promise in monkey trial
GlaxoSmithKline (GSK.L) and CureVac (5CV.DE) said a study on macaque monkeys showed their jointly-developed mRNA COVID-19 vaccine candidate to be "strongly improved" in protecting against ...
India is trying to secure tens of millions of doses of Pfizer, Moderna and J&J Covid-19 vaccines as it seeks to ramp up its immunization campaign. Just 8% of population is fully vaccinated. https://t.co/F86ggXw5Rz reports @rovingrajesh
Open
India Looks to Western Covid-19 Vaccines to Ease Supply Shortage
India, which was hit hard by a surge in coronavirus infections this spring, has struggled to ramp up its immunization campaign.
MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China
https://t.co/Y6N3TnF4Oo
OpenMorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China
Media Release MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China Planegg/Munich, Germany - August 17, …